September 22, 2022
Jefferson Investigates: COVID Risks, RNA in Cancer, and a New Use for Anti-nausea Medication
Long-non-coding RNA as a common driving force in cancer, blood analysis reveals COVID-19 risks, and a common drug finds a new application.